Adulterated: Prepared, packed, or held under insanitary conditions whereby it may have become contaminated
An FDA foreign inspection (Form FDA 483) or cGMP audit found systemic facility sanitation failures, non-sterile ophthalmic/OTC water systems, or pest harborage.
Form FDA 766 Relabeling / Reconditioning Playbook
Step-by-Step CBP & FDA ITACS Response Sequence:
- 1Determine immediately whether detention stems from a facility-wide Form FDA 483 / Warning Letter (Import Alert 66-40 or 99-39) or a container-level sanitation failure.
- 2If facility-wide cGMP DWPE applies, demand the factory's Establishment Inspection Report (EIR) and CAPA closure documentation before paying any remaining supplier invoices.
- 3For sterile ophthalmic/OTC products, commission USP <71> Sterility and USP <85> Bacterial Endotoxins testing while counsel negotiates with CDER Office of Manufacturing Quality.
- 4File a formal Import Alert Removal Petition once third-party cGMP re-inspection confirms all Form 483 observations are closed.
Private Lab Packet (PLAP) & Importer Checklist
Third-party cGMP / 21 CFR 211 / 21 CFR 111 on-site mock FDA audit + USP <71> Sterility / USP <61> Microbial Enumeration.
- Obtain the overseas manufacturer's full Form FDA 483 Establishment Inspection Report (EIR) and CAPA response timeline.
- Verify whether the facility has been placed on Import Alert 66-40 (cGMP Drug/OTC) or 99-39 before shipping additional containers.
- Retain US FDA regulatory counsel to submit an independent cGMP verification audit and petition for removal from DWPE.
Overseas Suppliers Cited for INSANITARY_CONDITIONS (1)
Download Normalized 5-Year Refusal, 483 & Recall Audit Workbook (.XLSX + CSV)
Includes all deduplicated overseas factory names, FEI/DUNS crosswalks, 5-year port refusal logs, plain-English statutory violation mappings, and FSVP supplier qualification templates ready for customs broker review.
- Full 5-year OASIS refusal history for Ahmedabad Sterile Ophthalmics & Pharma Ltd. + category peers
- 21 CFR 1.505 Foreign Supplier Verification Program (FSVP) audit checklist tab
Instant Supplier Detention Webhook & Email Alert Monitor
Get an automated Slack/Webhook JSON payload and email alert within 15 minutes whenever FDA OASIS logs a new detention, Import Alert Red List addition, or Warning Letter for Ahmedabad Sterile Ophthalmics & Pharma Ltd. before you wire your 70% balance payment.
Shipment Detained by FDA or Placed on Import Alert? Request Free 24h Detention Evaluation from Licensed US FDA Compliance Counsel
When FDA issues a Notice of FDA Action (Detention), importers typically have only 10 to 20 business days to file a Form FDA 766 relabeling application, submit an accredited private laboratory packet (PLAP), or petition for Import Alert Red List removal before CBP orders refusal and liquidated damages.
Charge Code INSANITARY_CONDITIONS FAQ
What does FDA Charge Code INSANITARY_CONDITIONS (FD&C Act Section 402(a)(4) / 501(a)(2)(A)) mean on a Notice of FDA Action?
Adulterated: Prepared, packed, or held under insanitary conditions whereby it may have become contaminated. In plain English: An FDA foreign inspection (Form FDA 483) or cGMP audit found systemic facility sanitation failures, non-sterile ophthalmic/OTC water systems, or pest harborage.
Can a shipment detained for INSANITARY_CONDITIONS be released via Form FDA 766 relabeling?
NOT ELIGIBLE FOR FORM 766 OR SINGLE-LOT LAB RELEASE WHEN UNDER cGMP IMPORT ALERT 66-40: Because Section 402(a)(4) / 501(a)(2)(A) means the product 'may have become contaminated' due to systemic plant conditions, finished-product testing alone usually cannot overcome a cGMP Import Alert 66-40 detention. Final authorization always rests with the reviewing FDA District Import Compliance Office.